As shown in Fig. 5, the incidence of subcutaneous tumor formation in the thymectomized mice receiving CD133+ glioblastoma cells was 26/30 at 28 days post-transfer, compared with 2/30 in the CD133− glioblastoma cell group. This evidence concerns the gene PROM1 and neoplasm.